BridgeMD
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associated with de novo atrial Fibrillation Arrhythmia (SCA-FA): An exploratory prospective multicenter study
EU CTIS ID: 2024-515433-15-02
What this study is testing
To compare the risk of haemorrhage (BARC event >=2 at 2 years) between the standard group and the intervention group with anticoagulation controlled by an implantable holter with teleradiology. Due to the included patient’s number and the a priori power of the study, it will only be descriptive in scope.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients, aged ≥18.
- Hospitalization for acute coronary syndrome with or without ST segment elevation
- Atrial fibrillation present at the time of patient arrival at the hospital or occurring at any time during hospitalization. Patient without any prior known history of arrhythmia.
- Chads2vas SCORE ≥ 1 for men and ≥ 2 for women
- Ablation of atrial fibrillation before enrollment in the study. The atrial fibrillation ablation can be spontaneous or obtained by treatment
- Coronary angioplasty with stenting should be done during the hospitalization
You likely can't join if
- Atrial fibrillation diagnosed before hospitalization for acute coronary syndrome, whether treated or not
- Atrial fibrillation still present at inclusion time
- Patient already on anticoagulant therapy
- Creatinine clearance < 30 ml per minute
- Contraindications to anticoagulant therapy
- Active internal hemorrhage, clinically significant bleeding, bleeding non accessible to compression or bleeding diathesis within 30 days prior to selection visit
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.